T2 Protein 800 807 HLA LOH
T3 Gene 670 689 HLA LOH alterations
T4 Condition 487 493 cancer
T5 Gene 441 446  HLA 
T6 Gene 90 114 human leukocyte antigen 
T7 Intervention 1110 1121 neoantigens
T8 Protein 670 677 HLA LOH
T9 Protein 224 227 HLA
T10 Gene 293 317 human leukocyte antigen 
T11 Condition 32 38 cancer
T12 Protein 442 449 HLA LOH
T13 Protein 442 445 HLA
T14 Gene 360 365  HLA 
T15 Condition 912 917 tumor
T16 Protein 224 239 HLA copy-number
T17 Gene 734 750 metastatic sites
T19 Protein 424 427 HLA
T20 Gene 195 200 locus
T21 Protein 361 364 HLA
T22 Protein 800 803 HLA
T23 Gene 119 124  loss
T24 Gene 223 228  HLA 
T25 Gene 420 427  LOHHLA
T26 Intervention 70 81 neoantigens
T27 Protein 670 673 HLA
T28 Gene 956 963  LOHHLA
T31 Protein 321 324 HLA
T32 Protein 318 324 LOHHLA
T33 Protein 944 947 HLA
T34 Gene 669 674  HLA 
T35 Protein 944 951 HLA LOH
T36 Gene 169 180 polymorphic
T37 Gene 799 804  HLA 
T38 Gene 943 948  HLA 
T39 Biomarker 632 637 PD-L1
T40 Gene 266 271  loss
T42 Condition 496 502 NSCLCs
T43 Protein 115 118 HLA
